(IXJ) Global Healthcare - Overview
Etf: Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Providers
| Risk 5d forecast | |
|---|---|
| Volatility | 15.5% |
| Relative Tail Risk | -0.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -5.81 |
| Character TTM | |
|---|---|
| Beta | 0.415 |
| Beta Downside | 0.372 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.14% |
| CAGR/Max DD | 0.44 |
Description: IXJ Global Healthcare March 04, 2026
IXJ is an Exchange Traded Fund (ETF) that primarily invests in global healthcare companies. The fund allocates at least 80% of its assets to securities within its underlying index, which tracks the performance of healthcare sector companies deemed important to global markets. The healthcare sector is characterized by a diverse range of businesses including pharmaceuticals, biotechnology, medical devices, and healthcare services.
Up to 20% of IXJs assets may be held in futures, options, swap contracts, cash, and cash equivalents. This allows for flexibility in managing the fund and potentially hedging against market fluctuations. Understanding the specific companies and their business models within this ETF can provide deeper insights. Further research on ValueRay can offer detailed analytics on IXJs holdings and their individual performance.
Headlines to watch out for
- Global pharmaceutical sales growth impacts healthcare sector revenue
- Medical device innovation drives industry expansion
- Healthcare policy changes introduce regulatory risks
- Aging global population increases demand for medical services
What is the price of IXJ shares?
Over the past week, the price has changed by -2.37%, over one month by -5.35%, over three months by -1.62% and over the past year by +5.97%.
Is IXJ a buy, sell or hold?
What are the forecasts/targets for the IXJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |